Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Tax Withholding |
2025-03-04 5:00 pm |
N/A N/A |
AbbVie Inc. | ABBV | Thakkar Roopal EVP, R&D and CSO |
4,678 | $205.02 | 42,276 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 5:00 pm |
N/A 2035-02-12 |
AbbVie Inc. | ABBV | Thakkar Roopal EVP, R&D and CSO |
35,555 | $0 | 71,954 (Direct) |
View |
| 2024-02-15 Option Award(A) |
2025-02-07 4:00 pm |
2025-02-15 2034-02-14 |
AbbVie Inc. | ABBV | Thakkar Roopal EVP, R&D and CSO |
24,956 | $0 | 55,181 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-03-01 5:50 pm |
N/A N/A |
AbbVie Inc. | ABBV | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS |
4,914 | $178.99 | 23,259 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:15 pm |
2025-02-15 2034-02-14 |
AbbVie Inc. | ABBV | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS |
31,664 | $0 | 42,041 (Direct) |
View |
Ownership |
2023-12-22 4:13 pm |
N/A N/A |
AbbVie Inc. | ABBV | Thakkar Roopal SVP, Global Therapeutics & CMO |
0 | $0 | 71,098 (Direct) |
View |